Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 90

1.

Inhibition of endotrophin, a cleavage product of collagen VI, confers cisplatin sensitivity to tumours.

Park J, Morley TS, Scherer PE.

EMBO Mol Med. 2013 Jun;5(6):935-48. doi: 10.1002/emmm.201202006. Epub 2013 Apr 30.

PMID:
23629957
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Adipocyte-derived endotrophin promotes malignant tumor progression.

Park J, Scherer PE.

J Clin Invest. 2012 Nov;122(11):4243-56. doi: 10.1172/JCI63930. Epub 2012 Oct 8.

PMID:
23041627
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Endotrophin triggers adipose tissue fibrosis and metabolic dysfunction.

Sun K, Park J, Gupta OT, Holland WL, Auerbach P, Zhang N, Goncalves Marangoni R, Nicoloro SM, Czech MP, Varga J, Ploug T, An Z, Scherer PE.

Nat Commun. 2014 Mar 19;5:3485. doi: 10.1038/ncomms4485.

PMID:
24647224
[PubMed - indexed for MEDLINE]
4.

Endotrophin - a novel factor linking obesity with aggressive tumor growth.

Park J, Scherer PE.

Oncotarget. 2012 Dec;3(12):1487-8. No abstract available.

PMID:
23455368
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Remission of human breast cancer xenografts on therapy with humanized monoclonal antibody to HER-2 receptor and DNA-reactive drugs.

Pietras RJ, Pegram MD, Finn RS, Maneval DA, Slamon DJ.

Oncogene. 1998 Oct 29;17(17):2235-49.

PMID:
9811454
[PubMed - indexed for MEDLINE]
Free Article
6.

Adipocyte-derived collagen VI affects early mammary tumor progression in vivo, demonstrating a critical interaction in the tumor/stroma microenvironment.

Iyengar P, Espina V, Williams TW, Lin Y, Berry D, Jelicks LA, Lee H, Temple K, Graves R, Pollard J, Chopra N, Russell RG, Sasisekharan R, Trock BJ, Lippman M, Calvert VS, Petricoin EF 3rd, Liotta L, Dadachova E, Pestell RG, Lisanti MP, Bonaldo P, Scherer PE.

J Clin Invest. 2005 May;115(5):1163-76. Epub 2005 Apr 14.

PMID:
15841211
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

PPARgamma activation by thiazolidinediones (TZDs) may modulate breast carcinoma outcome: the importance of interplay with TGFbeta signalling.

Jarrar MH, Baranova A.

J Cell Mol Med. 2007 Jan-Feb;11(1):71-87. Review.

PMID:
17367502
[PubMed - indexed for MEDLINE]
8.

Vascular endothelial growth factor immunoneutralization in combination with cisplatin reduces EAC tumor growth.

Ghosh S, Maity P.

Int Immunopharmacol. 2006 Oct;6(10):1550-9. Epub 2006 Jun 30.

PMID:
16919827
[PubMed - indexed for MEDLINE]
9.

Remodeling of the extracellular matrix through overexpression of collagen VI contributes to cisplatin resistance in ovarian cancer cells.

Sherman-Baust CA, Weeraratna AT, Rangel LB, Pizer ES, Cho KR, Schwartz DR, Shock T, Morin PJ.

Cancer Cell. 2003 Apr;3(4):377-86.

PMID:
12726863
[PubMed - indexed for MEDLINE]
10.

Tumor-specific expression and alternative splicing of the COL6A3 gene in pancreatic cancer.

Arafat H, Lazar M, Salem K, Chipitsyna G, Gong Q, Pan TC, Zhang RZ, Yeo CJ, Chu ML.

Surgery. 2011 Aug;150(2):306-15. doi: 10.1016/j.surg.2011.05.011. Epub 2011 Jun 30.

PMID:
21719059
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Evaluation of hyperbaric oxygen as a chemosensitizer in the treatment of epithelial ovarian cancer in xenografts in mice.

Alagoz T, Buller RE, Anderson B, Terrell KL, Squatrito RC, Niemann TH, Tatman DJ, Jebson P.

Cancer. 1995 May 1;75(9):2313-22.

PMID:
7536123
[PubMed - indexed for MEDLINE]
12.

HO-3867, a curcumin analog, sensitizes cisplatin-resistant ovarian carcinoma, leading to therapeutic synergy through STAT3 inhibition.

Selvendiran K, Ahmed S, Dayton A, Kuppusamy ML, Rivera BK, Kálai T, Hideg K, Kuppusamy P.

Cancer Biol Ther. 2011 Nov 1;12(9):837-45. doi: 10.4161/cbt.12.9.17713. Epub 2011 Nov 1.

PMID:
21885917
[PubMed - indexed for MEDLINE]
Free Article
13.

Collagen VI in cancer and its biological mechanisms.

Chen P, Cescon M, Bonaldo P.

Trends Mol Med. 2013 Jul;19(7):410-7. doi: 10.1016/j.molmed.2013.04.001. Epub 2013 Apr 30. Review.

PMID:
23639582
[PubMed - indexed for MEDLINE]
14.

A novel charged trinuclear platinum complex effective against cisplatin-resistant tumours: hypersensitivity of p53-mutant human tumour xenografts.

Pratesi G, Perego P, Polizzi D, Righetti SC, Supino R, Caserini C, Manzotti C, Giuliani FC, Pezzoni G, Tognella S, Spinelli S, Farrell N, Zunino F.

Br J Cancer. 1999 Aug;80(12):1912-9.

PMID:
10471039
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Thiazolidinedione-dependent activation of sphingosine kinase 1 causes an anti-fibrotic effect in renal mesangial cells.

Koch A, Völzke A, Wünsche C, Meyer zu Heringdorf D, Huwiler A, Pfeilschifter J.

Br J Pharmacol. 2012 Jun;166(3):1018-32. doi: 10.1111/j.1476-5381.2012.01824.x.

PMID:
22221312
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Derivation and initial characterization of a mouse mammary tumor cell line carrying the polyomavirus middle T antigen: utility in the development of novel cancer therapeutics.

Nielsen LL, Gurnani M, Shi B, Terracina G, Johnson RC, Carroll J, Mathis JM, Hajian G.

Cancer Res. 2000 Dec 15;60(24):7066-74.

PMID:
11156413
[PubMed - indexed for MEDLINE]
Free Article
17.

Lurbinectedin (PM01183), a new DNA minor groove binder, inhibits growth of orthotopic primary graft of cisplatin-resistant epithelial ovarian cancer.

Vidal A, Muñoz C, Guillén MJ, Moretó J, Puertas S, Martínez-Iniesta M, Figueras A, Padullés L, García-Rodriguez FJ, Berdiel-Acer M, Pujana MA, Salazar R, Gil-Martin M, Martí L, Ponce J, Molleví DG, Capella G, Condom E, Viñals F, Huertas D, Cuevas C, Esteller M, Avilés P, Villanueva A.

Clin Cancer Res. 2012 Oct 1;18(19):5399-411. doi: 10.1158/1078-0432.CCR-12-1513. Epub 2012 Aug 15.

PMID:
22896654
[PubMed - indexed for MEDLINE]
Free Article
18.

EMT transcription factors snail and slug directly contribute to cisplatin resistance in ovarian cancer.

Haslehurst AM, Koti M, Dharsee M, Nuin P, Evans K, Geraci J, Childs T, Chen J, Li J, Weberpals J, Davey S, Squire J, Park PC, Feilotter H.

BMC Cancer. 2012 Mar 19;12:91. doi: 10.1186/1471-2407-12-91.

PMID:
22429801
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Interleukin-2: hope in cases of cisplatin-resistant tumours.

Bernsen MR, Van Der Velden AW, Everse LA, Dullens HF, Den Otter W, Heintz AP.

Cancer Immunol Immunother. 1998 Mar;46(1):41-7.

PMID:
9520291
[PubMed - indexed for MEDLINE]
20.

[Effects of Zengmian Yiliu Recipe combined cisplatin on the tumor inhibition rate in platinum-resistant ovarian cancer].

Qi C, Zhang QH, Li JX.

Zhongguo Zhong Xi Yi Jie He Za Zhi. 2012 Jun;32(6):817-21. Chinese.

PMID:
22978111
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk